Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
FUT3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
CTAGE5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
PACRG-AS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
STX7 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CARD8 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FAM135A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
KCNE1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MYH7 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LINC00260 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
VANGL1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RBMS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FOXD3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SLC39A5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LECT1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CLCN5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
AMMECR1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LINC00226 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on